Carboplatin Triple Negative Breast Cancer

PDF - Breast Cancer Research
RESEARCH ARTICLE Open Access Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer Jasmeet Chadha Singh1, Yelena Novik2, Stacey Stein3, Matthew Volm2, Marlene Meyers2,JuliaSmith2, Coral Omene2, ... Fetch This Document

Olaparib Carboplatin Combination Showed Early Signs Of ...
Four of the triple-negative breast cancer patients had a germline BRCA mutation. The patients were randomized to one of two treatment arms: in arm A, patients received olaparib carboplatin (C) in recurrent women’s cancers (NCT01237067) ... Return Doc

Tailoring Adjuvant Chemotherapy Regimens For ... - The Breast
Negative breast cancer. In the TNT trial, patients with metastatic triple negative breast cancer were randomized to docetaxel or carboplatin [13]. ... Retrieve Content

A Phase II Clinical Trial Of Weekly Paclitaxel And ...
A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer S Cowherd1, L D Miller1, S A Melin1, S Akman1, S Isom1, J Cole2, A Pullikuth1, and J A Lawrence1,* ... Retrieve Doc

Targeted Chemotherapy? Platinum In BRCA1-Dysfunctional Breast ...
Platinum in BRCA1-Dysfunctional Breast Cancer tin or carboplatin in metastatic triple-negative disease focused on triple-negative breast cancer (BC). 2006 San Antonio Breast Cancer Symposium, San Antonio, TX, December 14-17, 2006 ... Retrieve Here

Metastatic Or Recurrent Locally Advanced triple negative Or ...
TNT: A randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012) ... Access This Document

Ángel Jiménez Lacave - Wikipedia, La Enciclopedia Libre
En su triple faceta "Randomized phase II and III study in first line hormonal treatment for metastatic breast cancer with Exemestane "A randomized phase III study comparing Gemcitabine plus Carboplatin versus Carboplatin monotherapy in patients with advanced epithelial ovarian ... Read Article

STUDY PROTOCOL Open Access Phase II/III Weekly Nab
STUDY PROTOCOL Open Access Phase II/III weekly nab gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol /carboplatin (C)/bevacizumab(B) for triple-negative metastatic breast cancer (TNMBC ... Retrieve Content

Phase II Neoadjuvant Clinical Trial Of carboplatin And ...
CLINICAL TRIAL Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579) ... Document Viewer

Neoadjuvant Carboplatin Improved DFS For Triple-Negative ...
“Patients with triple-negative breast cancer who received carboplatin as part of their neoadjuvant http://www.cancernetwork.com/sabcs-2015/neoadjuvant-carboplatin-improved-dfs-triple-negative-breast-cancer. ... View Doc

Personalized Medicine For Triple Negative Breast Cancer - New ...
Personalized Medicine for Triple Negative Breast Cancer - New Dimensions in Therapeutic Individualization Bryan P. Schneider & Milan Radovich Carboplatin BSI-201 21 day cycle Gem/carbo (n=44) Gem/carbo/BSI (n=42) P-value ORR 7 (16%) 20 (48%) 0.002 ... Retrieve Content

Metastatic Triple Negative Breast Cancer: The TNT Trial ...
Metastatic Triple Negative Breast Cancer: The TNT Trial Comparing Two Older Drugs Head to Head The TNT clinical trial was conducted in the United Kingdom with enrollment beginning August 2008, and recruitment ending March 2014. (Taxotere) or Carboplatin? ... Get Document

Stage 2 Breast Cancer: Diagnosis, Treatment, Survival
Stage 2 breast cancer is an early-stage tumor and should respond well to proper treatment. Learn how that affects your options and survival. About.com; Autos; Careers; Dating & Relationships; Education; en Español; Entertainment; Food; Health; Home; Money; ... Read Article

Nab-Paclitaxel/Bevacizumab/Carboplatin Chemotherapy In First ...
Nab-Paclitaxel/Bevacizumab/Carboplatin Chemotherapy in First-Line Triple Negative Metastatic Breast Cancer Triple negative breast cancer (TNBC) refers to a subgroup of breast carcinomas that do not express the estrogen receptor, pro- ... Retrieve Content

Is Neoadjuvant Or Adjuvant Chemotherapy Better For Breast ...
SUBSCRIBE FOR MORE EXPERT INFORMATION AND BREAKING BREAST CANCER NEWS Sara M. Tolaney on Neoadjuvant Treatment Considerations for Triple-Negative Breast Cancer - Duration: 1:09. curetoday 362 views. Neoadjuvant carboplatin/docetaxel chemotherapy in TNBC ... View Video

Triple negative Breast Cancer Patient - London Cancer
Triple Negative Breast Cancer: Definition Carbo=carboplatin; Cis=cisplatin; D=docetaxel; E=epirubicin; F=5-FU; H=trastuzumab; P=paclitaxel; retro=retrospective. TNT Trial n=450 KCL / ICR co-sponsors BRCA1 genotyping Naz Rahman ICR ... Access Document

Neoadjuvant carboplatin In Patients With triple-negative And ...
And HER2-positive early breast cancer (GeparSixto; GBG 66): Regimens were without (A) and with (B) carboplatin. TNBC=triple-negative breast cancer. Non-pegylated liposomal doxorubicin Paclitaxel Carboplatin R A B Surgery Bevacizumab (TNBC) ... Access Content

Triple Negative And Locoregional Therapy
Breast Cancer Triple Negative and Locoregional Therapy Stephen Chia MD, FRCP(C) Medical Oncologist Associate Professor of Medicine British Columbia Cancer Agency ... Get Document

Preoperative Treatment Of The Triple Negative (Basal ...
Preoperative Treatment of the Triple-Negative (Basal Phenotype) Breast Cancer. Judy E. Garber, MD MPH Dana Farber Cancer Institute. Boston, MA 26 March 2007 ... Retrieve Document

Carboplatin For Early triple-negative breast cancer? - The Lancet
Carboplatin for early triple-negative breast cancer? Anthracycline/taxane-based primary systemic therapy Carboplatin for early triple-negative breast cancer? Author: Vicente Valero Subject: Lancet Oncology, 15 (2014) 676-678. doi:10.1016/S1470-2045(14)70231-1 ... Access Document